Consucon (Gliclazide) is a second generation sulfonylurea drug that has hypoglycaemic and potentially useful haemobiological properties. It stimulates the release of insulin from pancreatic beta-cells by facilitating Ca+2 transport across the beta-cell membranes and decreases hepatic glucose output.
Drug information sourced from Incepta Pharma.
Non Otc
Daily Needs
Fashion & Beauty
Kids Zone
Office Stationaries
Medicine
Health & Care
Gift Items